Indole derivatives and uses thereof
AssigneeNovartis AG
InventorsJohn Ryan Kerrigan, Natalie Dales, George Scott Tria, Daniel Palacios, Paul Gormisky
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a compound of formula (I): or a pharmaceutically acceptable salt thereof, and its therapeutic uses for activating a growth factor pathway, promoting wound healing, promoting tissue repair, and treating hearing loss, skeletal muscle loss, organ degeneration, tissue damage, neurodegeneration, and muscular atrophy. The disclosure further provides pharmaceutical compositions and combinations. The present disclosure also relates to the use of such compounds for research or other non-therapeutic purposes.
Claims31
A compound of formula (I) or a pharmaceutically acceptable salt thereof:
- wherein:
- L is absent, O, S, NHCO or CONH;
- X is CH or N;
- R1 is H, C1-4alkyl, C1-4haloalkyl, or 3-6 membered cycloalkyl;
- R2 is H, —OH, halo, —CN, nitro, C1-4alkoxy, C1-4alkyl, C1-4alkoxy-C1-4alkyl, C1-4haloalkyl, C1-4hydroxyalkyl, a 5-10 membered heterocyclyl optionally substituted with 1-3 C1-4alkyl groups, —(CH2)n-(6 or 10 membered aryl optionally substituted with 1-3 C1-4alkyl groups), or —(CH2)n-(5-10 membered heteroaryl optionally substituted with 1-3 C1-4alkyl groups);
- R3 is H, halo, —OH, C1-4alkyl, C1-4alkoxy, C1-4haloalkyl or C1-4 haloalkoxy;
- R4 is a substituted C2-4alkynyl, a substituted or unsubstituted 5-10 membered heterocyclyl, a substituted or unsubstituted 5-10 membered heteroaryl, a substituted or unsubstituted 5-10 membered fused heterocyclyl-aryl, a substituted or unsubstituted 5-10 membered fused heterocyclyl-heteroaryl, or a substituted or unsubstituted 6 or 10 membered aryl, wherein when R4 is substituted, R4 is substituted with 1-3 substituents independently selected from halo, —OH, oxo (═O), —CN, nitro, C1-4alkyl, —C1-4alkyl-(3-6 membered cycloalkyl), C1-4alkoxy, —SO2—C1-4alkyl, —SO2—C1-4hydroxyalkyl, —SO2—C1-4alkyl-NR5R6, —NHSO2—C1-4alkyl, C1-4hydroxyalkyl, —SO2NR5R6, —CO—C1-4hydroxyalkyl, —CONR5R6, —CO—C1-4alkyl-NR5R6, —CO—NH—C1-4alkyl-NR5R6, —NR5R6, —C1-4alkyl-NR5R6 and —CO—C1-4alkyl;
- R5 and R6 are each, independently, selected from H, C1-4alkyl, C1-4hydroxyalkyl, —CO—C1-4alkyl and -(4-10 membered heterocyclyl)-C1-4alkyl;
- or R5 and R6, together with the nitrogen atom to which they are attached, form a 5-7 membered heterocyclyl optionally substituted with 1-3 C1-4alkyl groups;
- and
- n is 0 or 1.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.